Pharming Group N.V. PHGUF
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 131.42% | -197.84% | -29.41% | 60.80% | 131.89% |
| Total Depreciation and Amortization | -8.41% | 34.72% | -15.15% | 0.89% | 4.65% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 10.71% | 26.10% | -58.99% | -26.48% | -13.43% |
| Change in Net Operating Assets | -4,176.40% | 164.96% | -104.63% | 388.06% | -461.66% |
| Cash from Operations | -594.77% | -81.77% | -66.57% | 172.72% | 4,961.64% |
| Capital Expenditure | 65.13% | 11.52% | -284.29% | 45.31% | 54.61% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | 100.00% |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 100.00% | -37,833.04% | 180.29% | -101.63% | -74.67% |
| Cash from Investing | 99.90% | -188,255.56% | 87.11% | -102.06% | 74.96% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 92.92% | -848.46% | -24.82% | -2.81% | -49.09% |
| Issuance of Common Stock | -68.54% | -26.12% | -60.47% | 1,169.31% | 334.02% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -2,097.60% | 95.60% | -26.47% | 17.87% | 56.17% |
| Cash from Financing | 73.48% | -988.44% | -89.55% | 460.28% | 58.97% |
| Foreign Exchange rate Adjustments | 132.63% | -172.47% | 192.86% | -121.96% | 211.41% |
| Miscellaneous Cash Flow Adjustments | 11,779,800.00% | -- | 100.00% | -- | -- |
| Net Change in Cash | 213.96% | -818.41% | -67.89% | 25.88% | 521.44% |